πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 11 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11911359

Stimulation of an immune response by cationic lipids

PDS Biotechnology Corporation Β· Granted Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11911465

Vaccine compositions and methods of use

PDS Biotechnology Corporation Β· Granted Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11904015

Vaccine compositions and methods of use

PDS Biotechnology Corporation Β· Granted Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11801257

Stimulation of an immune response by enantiomers of cationic lipids

PDS Biotechnology Corporation Β· Granted Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11638753

Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dend

PDS Biotechnology Corporation Β· Granted Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11612652

Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dend

PDS Biotechnology Corporation Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11401306

HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof

PDS Biotechnology Corporation Β· Granted Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10702541

Stimulation of an immune response by enantiomers of cationic lipids

PDS Biotechnology Corporation Β· Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9789129

Stimulation of an immune response by enantiomers of cationic lipids

PDS Biotechnology Corporation Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8877206

Stimulation of an immune response by cationic lipids

PDS Biotechnology Corporation Β· Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7303881

Antigen delivery compositions and methods of use

PDS Biotechnology Corporation Β· Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted